Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTime Finance Regulatory News (TIME)

Share Price Information for Time Finance (TIME)

Share Price is delayed by 15 minutes
Get Live Data
46.00    0.75 (1.66%)
Bid:
45.00
Ask:
47.00
Spread: 2.00 (4.444%)
Market Cap: £42.17m
TIME Live PriceLast checked at - London Stock Exchange

Intraday Time Finance Share Chart

New Product Launch - TimestripPlus

25 Mar 2009 07:00

RNS Number : 3939P
Timestrip PLC
25 March 2009
 

25 March 2009

TIME.L

Timestrip plc

("Timestrip")

New Product Launch - TimestripPlus

The Company is delighted to announce the launch of TimestripPlus - a cost-effective and simple-to-use indicator that shows if a product has been exposed to temperature abuse during storage or transit and for how long that temperature abuse lasted.

Developed from the Company's existing technology platform, TimestripPlus uses a range of specially formulated materials that each has a specific melt and freeze point. When that melting point is reached the material migrates in a controlled way through the label, and only stops once it returns to its freeze point. In this way it is possible to see at a glance how long a product spent above its safe storage temperature, even if it was at some stage returned to the correct temperature.

TimestripPlus is targeted as a cold chain tool for temperature sensitive products in the pharmaceutical, healthcare and food sectors, where the financial and safety consequences of temperature breaches are considerable. TimestripPlus are easy to use, do not require special conditioning before activation, and are easy to interpret.

The Company is delighted to announce that its distributor, Fingerprint Data Systems UK, through one of its key partners, has already secured trial orders of TimestripPlus in two large UK hospital sites. Focusing on the pharmacy supply chain, Timestrip Plus is being used to ensure that products released from the hospital pharmacy are not spending excessive periods of time above the correct temperature. 

There are two stock products currently available for the following temperature thresholds: 12ºC (54ºF) for chilled products and 0ºC (32ºF) for frozen products. The Company expects to bring additional products to market with different temperature thresholds during 2009. Additional information on TimestripPlus is available from www.timestrip.com/cold_chain_home.php

Reuben Isbitsky, Joint CEO Timestrip Plc comments: "We are excited to introduce this product to the market, which is the result of an intensive research and development effort over the last 18 months. TimestripPlus is manufactured using existing machinery and expertise and complements the existing product range and sales effort. We believe that there is a significant market potential for this product and expect to continue to receive strong interest from several sectors."

Ends.

For more information please contact:

Reuben Isbitsky, Joint CEO, Timestrip Plc 01462 440700

Geoff Nash, FinnCap, NOMAD 020 7600 1658

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAGGGZFKDNGLZM
Date   Source Headline
9th Jun 20267:00 amRNSLending Book Milestone & Notice of Q4 Update
24th Mar 20267:00 amRNSQ3 Trading Update
16th Mar 20267:00 amRNSNotice of Trading Update
16th Mar 20267:00 amRNSNotice of Trading Update
27th Jan 20267:00 amRNSInterim Results
16th Dec 20257:00 amRNSHalf-Year Trading Update & Notice of Results
19th Nov 20257:00 amRNSGrant of 2025 LTIP Awards
14th Nov 20251:57 pmRNSExercise of Options & Director/PDMR Shareholdings
12th Nov 20257:00 amRNSLoan Book Update
6th Nov 202512:07 pmRNSResult of AGM
28th Oct 20257:00 amRNSNotice of Trading Update & Investor Presentations
3rd Oct 20257:00 amRNSVesting of Option Awards
26th Sep 20257:00 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSNotice of AGM
24th Sep 20257:01 amRNSQ1 Trading Update
24th Sep 20257:00 amRNSFinal Results
18th Sep 20257:00 amRNSNotice of Results, Investor Presentation and AGM
1st Aug 20257:00 amRNSExtended Funding Facilities
26th Jun 20257:00 amRNSTrading Update and Notice of Final Results
4th Jun 20257:00 amRNSLaunch of New Investor Hub
6th May 20257:00 amRNSNotice of Q4 Trading Update and of Final Results
25th Mar 20257:00 amRNSQ3 Trading Update
12th Mar 20257:00 amRNSNotice of Investor Presentation
3rd Mar 20257:00 amRNSDirector/PDMR Shareholding
28th Feb 20257:00 amRNSDirector/PDMR Shareholding
27th Feb 202512:00 pmRNSNotice of Trading Update
11th Feb 20257:00 amRNSLending Portfolio Update
28th Jan 20257:00 amRNSInterim Results
19th Dec 20247:00 amRNSHalf-Year Trading Update & Notice of Results
22nd Nov 20249:03 amRNSHolding(s) in Company
12th Nov 20247:00 amRNSTrading Update
5th Nov 202412:30 pmRNSResult of AGM
24th Oct 20247:00 amRNSExercise of Options & Director/PDMR Shareholdings
4th Oct 20247:00 amRNSVesting of Option Awards
3rd Oct 20247:00 amRNSDirector share purchases
2nd Oct 20247:00 amRNSExtended & Improved £65m NatWest Funding Facility
26th Sep 20247:00 amRNSNotice of AGM
25th Sep 20247:01 amRNSQ1 Trading Update
25th Sep 20247:00 amRNSFinal Results
10th Sep 20247:00 amRNSNotice of Results, Investor Pres & Trading Update
27th Aug 20247:00 amRNSGrowth Guarantee Scheme Accreditation
3rd Jul 20247:00 amRNSDirector Share Purchase
27th Jun 20247:00 amRNSTrading Update and Notice of Final Results
3rd Apr 20247:00 amRNSExtended & Improved £64m Funding Facility
26th Mar 20247:00 amRNSQ3 Trading Update
5th Mar 20247:00 amRNSNotice of Trading Update
25th Jan 20247:00 amRNSInterim Results
18th Jan 20244:30 pmRNSHolding(s) in Company
19th Dec 20237:00 amRNSHalf-Year Trading Update & Notice of Results
21st Nov 20237:00 amRNSExercise of Options & Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.